These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25446323)

  • 1. Effects of mTOR inhibition on normal retinal vascular development in the mouse.
    Yagasaki R; Nakahara T; Mori A; Sakamoto K; Ishii K
    Exp Eye Res; 2014 Dec; 129():127-34. PubMed ID: 25446323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of mammalian target of rapamycin in the formation and progression of retinopathy of prematurity-like vascular abnormalities in neonatal rats.
    Nakano A; Morita A; Arima S; Nagamitsu T; Nakahara T
    Microvasc Res; 2024 Mar; 152():104626. PubMed ID: 37963514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pre- and post-natal treatment with KRN633, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, on retinal vascular development and patterning in mice.
    Morita A; Nakahara T; Abe N; Kurauchi Y; Mori A; Sakamoto K; Nagamitsu T; Ishii K
    Exp Eye Res; 2014 Mar; 120():127-37. PubMed ID: 24462631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of mid-pregnant mice with KRN633, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, induces abnormal retinal vascular patterning in their newborn pups.
    Morita A; Nakahara T; Abe N; Kurauchi Y; Mori A; Sakamoto K; Nagamitsu T; Ishii K
    Birth Defects Res B Dev Reprod Toxicol; 2014 Aug; 101(4):293-9. PubMed ID: 24831925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-angiogenic effects of mammalian target of rapamycin inhibitors in a mouse model of oxygen-induced retinopathy.
    Yagasaki R; Nakahara T; Ushikubo H; Mori A; Sakamoto K; Ishii K
    Biol Pharm Bull; 2014; 37(11):1838-42. PubMed ID: 25366488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term treatment with VEGF receptor inhibitors induces retinopathy of prematurity-like abnormal vascular growth in neonatal rats.
    Nakano A; Nakahara T; Mori A; Ushikubo H; Sakamoto K; Ishii K
    Exp Eye Res; 2016 Feb; 143():120-31. PubMed ID: 26500193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of an abnormal vascular patterning model in the mouse retina.
    Morita A; Sawada S; Mori A; Arima S; Sakamoto K; Nagamitsu T; Nakahara T
    J Pharmacol Sci; 2018 Apr; 136(4):177-188. PubMed ID: 29627228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient phenotypic changes in endothelial cells and pericytes in neonatal mouse retina following short-term blockade of vascular endothelial growth factor receptors.
    Morita A; Mori A; Arima S; Sakamoto K; Nagamitsu T; Ishii K; Nakahara T
    Dev Dyn; 2018 May; 247(5):699-711. PubMed ID: 29247590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal Vascular Phenotypes Associated with the Timing of Interruption of Retinal Vascular Development in Rats.
    Kondo R; Nakano A; Asano D; Morita A; Arima S; Mori A; Sakamoto K; Nagamitsu T; Nakahara T
    Biol Pharm Bull; 2020; 43(5):859-863. PubMed ID: 32378561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Anti-Diabetic Drug Metformin Suppresses Pathological Retinal Angiogenesis via Blocking the mTORC1 Signaling Pathway in Mice (Metformin Suppresses Pathological Angiogenesis).
    Yagasaki R; Morita A; Mori A; Sakamoto K; Nakahara T
    Curr Eye Res; 2024 May; 49(5):505-512. PubMed ID: 38251680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal neuronal cell loss prevents abnormal retinal vascular growth in a rat model of retinopathy of prematurity.
    Nakano A; Asano D; Kondo R; Mori A; Arima S; Ushikubo H; Sakamoto K; Nagamitsu T; Ishii K; Nakahara T
    Exp Eye Res; 2018 Mar; 168():115-127. PubMed ID: 29339088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling.
    Liu NN; Zhao N; Cai N
    IUBMB Life; 2015 Jun; 67(6):446-52. PubMed ID: 25988388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of retinal capillaries following N-methyl-D-aspartate-induced neurotoxicity in the neonatal rat retina.
    Asano D; Nakahara T; Mori A; Sakamoto K; Ishii K
    J Neurosci Res; 2015 Feb; 93(2):380-90. PubMed ID: 25284371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A delay in vascularization induces abnormal astrocyte proliferation and migration in the mouse retina.
    Morita A; Ushikubo H; Mori A; Arima S; Sakamoto K; Nagamitsu T; Ishii K; Nakahara T
    Dev Dyn; 2017 Mar; 246(3):186-200. PubMed ID: 28033674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis.
    Huber S; Bruns CJ; Schmid G; Hermann PC; Conrad C; Niess H; Huss R; Graeb C; Jauch KW; Heeschen C; Guba M
    Kidney Int; 2007 Apr; 71(8):771-7. PubMed ID: 17299523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of KRN633, an inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase, on vascular development of placenta and fetus of mid-pregnancy in mice.
    Wada Y; Ozaki H; Abe N; Nagamitsu T; Ohta H; Nakahara T; Ishii K
    J Pharmacol Sci; 2010; 112(3):290-8. PubMed ID: 20197639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of mTOR and Regulation by AMPK in Early Iodine Deficiency-Induced Thyroid Microvascular Activation.
    Craps J; Joris V; De Jongh B; Sonveaux P; Horman S; Lengelé B; Bertrand L; Many MC; Colin IM; Gérard AC
    Endocrinology; 2016 Jun; 157(6):2545-59. PubMed ID: 27035650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRN633, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, induces intrauterine growth restriction in mice.
    Abe N; Nakahara T; Morita A; Wada Y; Mori A; Sakamoto K; Nagamitsu T; Ishii K
    Birth Defects Res B Dev Reprod Toxicol; 2013 Aug; 98(4):297-303. PubMed ID: 23780833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mTOR/AP-1/VEGF signaling pathway regulates vascular endothelial cell growth.
    Wang S; Lu J; You Q; Huang H; Chen Y; Liu K
    Oncotarget; 2016 Aug; 7(33):53269-53276. PubMed ID: 27458160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic or mammalian target of rapamycin (mTOR) may determine robustness in young male mice at the cost of accelerated aging.
    Leontieva OV; Paszkiewicz GM; Blagosklonny MV
    Aging (Albany NY); 2012 Dec; 4(12):899-916. PubMed ID: 23443503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.